Drug companies on toes amid glare on USFDA – Times of India
MUMBAI: A US congressional panelhas voiced concern on the ineffective action on quality lapses taken by its national drug regulator Food and Drug Administration (FDA) particularly in manufacturing facilities in India and China. Together,!-->!-->…